Bio Green Med Solution, Inc. (BGMSP) Depreciation & Amortization (CF) (2010 - 2026)

Bio Green Med Solution (BGMSP) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $1000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) changed N/A year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $5000.0 (up 25.0% YoY), while the FY2025 annual figure was $5000.0, down 16.67% from the prior year.
• Depreciation & Amortization (CF) slipped to $1000.0 in Q1 2026 per BGMSP's latest filing, from $4000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $9000.0 in Q1 2022 and bottomed at $1000.0 in Q3 2024.
• Historically, Depreciation & Amortization (CF) has averaged $5285.7 across 5 years, with a median of $7000.0 in 2022.
• Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) sank 87.5% — and 2025, when it soared 300.0%.
• Bio Green Med Solution's Depreciation & Amortization (CF) stood at $8000.0 in 2022, then changed by 0.0% to $8000.0 in 2023, then tumbled by 87.5% to $1000.0 in 2024, then jumped by 300.0% to $4000.0 in 2025, then slumped by 75.0% to $1000.0 in 2026.
• Business Quant data shows BGMSP's Depreciation & Amortization (CF) at $1000.0 in Q1 2026, $4000.0 in Q4 2025, and $1000.0 in Q4 2024.